ZA79453B - 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds - Google Patents

6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Info

Publication number
ZA79453B
ZA79453B ZA79453A ZA79453A ZA79453B ZA 79453 B ZA79453 B ZA 79453B ZA 79453 A ZA79453 A ZA 79453A ZA 79453 A ZA79453 A ZA 79453A ZA 79453 B ZA79453 B ZA 79453B
Authority
ZA
South Africa
Prior art keywords
methylmercaptomethylergolines
methoxymethyl
propyl
related compounds
compounds
Prior art date
Application number
ZA79453A
Other languages
English (en)
Inventor
E Kornfeld
N Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA79453B publication Critical patent/ZA79453B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA79453A 1978-02-08 1979-02-02 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds ZA79453B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (1)

Publication Number Publication Date
ZA79453B true ZA79453B (en) 1980-09-24

Family

ID=25366703

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA79453A ZA79453B (en) 1978-02-08 1979-02-02 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Country Status (36)

Country Link
US (1) US4166182A (fi)
EP (1) EP0003667B1 (fi)
JP (1) JPS54115400A (fi)
AR (1) AR228341A1 (fi)
AT (1) AT371817B (fi)
AU (1) AU523172B2 (fi)
BE (1) BE873883A (fi)
BG (1) BG30474A3 (fi)
CA (1) CA1114368A (fi)
CH (1) CH639088A5 (fi)
CS (1) CS203951B2 (fi)
DD (1) DD141928A5 (fi)
DE (2) DE19375112I2 (fi)
DK (1) DK147362C (fi)
EG (1) EG14076A (fi)
ES (1) ES477547A1 (fi)
FI (1) FI65777C (fi)
FR (1) FR2416891A1 (fi)
GB (1) GB2014140B (fi)
GR (1) GR72776B (fi)
HU (1) HU179970B (fi)
IE (1) IE47827B1 (fi)
IL (1) IL56581A (fi)
LU (2) LU80886A1 (fi)
MX (2) MX5995E (fi)
MY (1) MY8500597A (fi)
NL (1) NL930106I2 (fi)
NZ (1) NZ189561A (fi)
PH (1) PH14903A (fi)
PL (3) PL124704B1 (fi)
PT (1) PT69172B (fi)
RO (3) RO81856A (fi)
SU (1) SU912045A3 (fi)
UA (1) UA6082A1 (fi)
YU (1) YU28279A (fi)
ZA (1) ZA79453B (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
ES2032570T3 (es) * 1987-11-20 1993-02-16 Farmitalia Carlo Erba S.R.L. Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe).
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
ES2082959T3 (es) * 1990-09-28 1996-04-01 I F L O S A S Di Giorgio E Ald Procedimiento para desarrollar la sintesis de una droga contraceptiva y de control del ciclo menstrual que tiene propiedades anticinetosicas, oncostaticas y terapeuticas para el tratamiento de los tumores de mama y melanomas.
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) * 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
AU2635599A (en) * 1999-03-17 2000-10-04 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
PT1401863E (pt) * 2001-06-08 2009-07-23 Ipsen Pharma Análogos quiméricos da somatostatina-dopamina
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
ATE414704T1 (de) * 2002-03-15 2008-12-15 Antibioticos Spa Verfahren zur synthese von pergolid
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (en) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Preparation of N-6 demethylated, 9,10-dihydrolysergic acid alkyl esters
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
WO2014070965A2 (en) 2012-11-01 2014-05-08 Ipsen Pharma S.A.S Somatostatin analogs and dimers thereof
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
EP2930175A4 (en) 2012-12-10 2016-12-21 Kissei Pharmaceutical NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF
CA2956257C (en) 2014-09-25 2022-07-12 Boehringer Ingelheim Vetmedica Gmbh Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
LU88294I2 (fr) 1994-05-04
MX5995E (es) 1984-09-18
IE47827B1 (en) 1984-06-27
PL124704B1 (en) 1983-02-28
DE19375112I2 (de) 2003-06-12
PH14903A (en) 1982-01-29
GB2014140B (en) 1982-08-04
NL930106I1 (nl) 1993-10-18
ATA91479A (de) 1982-12-15
EG14076A (en) 1983-12-31
UA6082A1 (uk) 1994-12-29
IL56581A0 (en) 1979-05-31
CA1114368A (en) 1981-12-15
BG30474A3 (en) 1981-06-15
CS203951B2 (en) 1981-03-31
FI790351A (fi) 1979-08-09
GR72776B (fi) 1983-12-05
FI65777B (fi) 1984-03-30
BE873883A (fr) 1979-08-02
DD141928A5 (de) 1980-05-28
US4166182A (en) 1979-08-28
PL126313B1 (en) 1983-07-30
PL120849B1 (en) 1982-03-31
AR228341A1 (es) 1983-02-28
PT69172A (en) 1979-03-01
EP0003667A1 (en) 1979-08-22
EP0003667B1 (en) 1982-07-14
JPS6363544B2 (fi) 1988-12-07
JPS54115400A (en) 1979-09-07
NZ189561A (en) 1981-12-15
RO81857A (ro) 1983-06-01
FR2416891B1 (fi) 1981-10-16
CH639088A5 (fr) 1983-10-31
LU80886A1 (fr) 1979-06-07
AU4391779A (en) 1979-08-16
PL213283A1 (fi) 1980-02-25
DE2963320D1 (en) 1982-09-02
DK147362B (da) 1984-07-02
RO81856B (ro) 1983-05-30
FI65777C (fi) 1984-07-10
YU28279A (en) 1983-02-28
DK51379A (da) 1979-09-18
MY8500597A (en) 1985-12-31
AT371817B (de) 1983-08-10
RO81857B (ro) 1983-05-30
ES477547A1 (es) 1980-04-16
FR2416891A1 (fr) 1979-09-07
RO76889A (ro) 1981-08-30
RO81856A (ro) 1983-06-01
IE790232L (en) 1979-08-08
IL56581A (en) 1982-05-31
PT69172B (pt) 1992-05-29
SU912045A3 (ru) 1982-03-07
MX9203107A (es) 1992-07-31
GB2014140A (en) 1979-08-22
HU179970B (en) 1983-01-28
AU523172B2 (en) 1982-07-15
NL930106I2 (nl) 1997-02-03
DK147362C (da) 1988-06-27

Similar Documents

Publication Publication Date Title
EG14076A (en) 6-n-propyl 1-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB2035310B (en) Indole-s-carbaxamides and this anologues
CS520079A2 (en) Nosna soustava snimaci hlavice
BG27580A1 (en) Two- poled pelvis- thight articulation- set
IL57801A0 (en) Fluorovitamin d compounds and their preparation
PH15021A (en) 6-n-propyl 8a-methoxymethyl or methylmercaptomethyl-ergolines and related compounds
CS333379A2 (en) Upinaci zarizeni
JPS5538394A (en) Imidazolylvinylether and its application
JPS5551072A (en) 44phenyll1*33benzodiazepin and its manufacture
JPS5569514A (en) 22ester substitutedd3*44dihydroo33 oxoquinoxalines
CS290179A2 (en) Plynova vybojka
JPS54130516A (en) Acyllnnacetylmuramylpeptide derivativeeantigen combination
JPS5553231A (en) 22propyllpentoo44enee11al* and its manufacture
JPS5520770A (en) Alkylthiophenoxyalkylamines
JPS5540662A (en) Hydrocortisonee17*211diester and its manufacture
JPS5549373A (en) 33chloroo33methyllbutanee or 33methyll22butenee1*44diaryllbisacetal and its manufacture
GB2022093B (en) Benzothalzocines and benzothiazonines
JPS5517367A (en) Bisstetrahydroisoquinolinium compounds and their manufacture
JPS53135955A (en) 111deoxyyomegaapentanolprostaglandin and like
JPS5585569A (en) Hexahydroo2*66methanoo33benzoazosine and its manufacture
GB2038350B (en) Sulphamphthaleins and sulphamnaphthaleins
JPS55102577A (en) Pyridinesulfonamides and its application
JPS54135782A (en) 11acetyll*33ootoluyl**55fluorouracil and its manufacture andantitumor
GB2020650B (en) 5-imino-4-hydroxymethyl-3-isoxazolidones having antitumouractivity
GB2019400A (en) 3-Oxo-Cyclopentyl-Ureas, -Thioureas and Guanendines